Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kohji Miura

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Clinical Calcium|December 3, 2013
[Clinical condition and therapy of bone diseases]Kohji Miura, Keiichi Oznono
Bone|July 6, 2013
A human skeletal overgrowth mutation increases maximal velocity and blocks desensitization of guanylyl cyclase-BJerid W Robinson, Deborah M Dickey, Kohji Miura, et al.
Hormone Research in Paediatrics|May 9, 2013
Detection and characterization of two novel mutations in the HNF4A gene in maturity-onset diabetes of the young type 1 in two Japanese familiesMakoto Fujiwara, Noriyuki Namba, Kohji Miura, et al.
Pediatric Endocrinology Reviews : PER|January 22, 2013
Pediatric aspects of skeletal dysplasiaKeiichi Ozono, Noriyuki Namba, Takuo Kubota, et al.
Journal of Bone and Mineral Metabolism|February 24, 2011
Decrease in serum FGF23 levels after intravenous infusion of pamidronate in patients with osteogenesis imperfectaTaichi Kitaoka, Noriyuki Namba, Kohji Miura, et al.
Clinical Pediatric Endocrinology : Case Reports and Clinical Investigations : Official Journal of the Japanese Society for Pediatric Endocrinology|August 9, 2013
A Japanese male patient with 'fibular aplasia, tibial campomelia and oligodactyly': an additional case reportTaichi Kitaoka, Noriyuki Namba, Ji Yoo Kim, et al.
Hormone Research in Paediatrics|March 1, 2014
Serum fibroblast growth factor 23 is a useful marker to distinguish vitamin D-deficient rickets from hypophosphatemic ricketsTakuo Kubota, Taichi Kitaoka, Kohji Miura, et al.
Bone|February 7, 2016
Successful induction of sclerostin in human-derived fibroblasts by 4 transcription factors and its regulation by parathyroid hormone, hypoxia, and prostaglandin E2Makoto Fujiwara, Takuo Kubota, Wei Wang, et al.
European Journal of Pediatrics|January 7, 2014
Two Japanese familial cases of Caffey disease with and without the common COL1A1 mutation and normal bone density, and review of the literatureTaichi Kitaoka, Yoko Miyoshi, Noriyuki Namba, et al.
American Journal of Medical Genetics. Part A|November 22, 2013
Overgrowth syndrome associated with a gain-of-function mutation of the natriuretic peptide receptor 2 (NPR2) geneKohji Miura, Ok-Hwa Kim, Hey Ran Lee, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Clinical Calcium|December 3, 2013
[Clinical condition and therapy of bone diseases]Kohji Miura, Keiichi Oznono
Bone|July 6, 2013
A human skeletal overgrowth mutation increases maximal velocity and blocks desensitization of guanylyl cyclase-BJerid W Robinson, Deborah M Dickey, Kohji Miura, et al.
Hormone Research in Paediatrics|May 9, 2013
Detection and characterization of two novel mutations in the HNF4A gene in maturity-onset diabetes of the young type 1 in two Japanese familiesMakoto Fujiwara, Noriyuki Namba, Kohji Miura, et al.
Pediatric Endocrinology Reviews : PER|January 22, 2013
Pediatric aspects of skeletal dysplasiaKeiichi Ozono, Noriyuki Namba, Takuo Kubota, et al.
Journal of Bone and Mineral Metabolism|February 24, 2011
Decrease in serum FGF23 levels after intravenous infusion of pamidronate in patients with osteogenesis imperfectaTaichi Kitaoka, Noriyuki Namba, Kohji Miura, et al.
Clinical Pediatric Endocrinology : Case Reports and Clinical Investigations : Official Journal of the Japanese Society for Pediatric Endocrinology|August 9, 2013
A Japanese male patient with 'fibular aplasia, tibial campomelia and oligodactyly': an additional case reportTaichi Kitaoka, Noriyuki Namba, Ji Yoo Kim, et al.
Hormone Research in Paediatrics|March 1, 2014
Serum fibroblast growth factor 23 is a useful marker to distinguish vitamin D-deficient rickets from hypophosphatemic ricketsTakuo Kubota, Taichi Kitaoka, Kohji Miura, et al.
Bone|February 7, 2016
Successful induction of sclerostin in human-derived fibroblasts by 4 transcription factors and its regulation by parathyroid hormone, hypoxia, and prostaglandin E2Makoto Fujiwara, Takuo Kubota, Wei Wang, et al.
European Journal of Pediatrics|January 7, 2014
Two Japanese familial cases of Caffey disease with and without the common COL1A1 mutation and normal bone density, and review of the literatureTaichi Kitaoka, Yoko Miyoshi, Noriyuki Namba, et al.
American Journal of Medical Genetics. Part A|November 22, 2013
Overgrowth syndrome associated with a gain-of-function mutation of the natriuretic peptide receptor 2 (NPR2) geneKohji Miura, Ok-Hwa Kim, Hey Ran Lee, et al.
Pageof 2